Contribution
I absolutely share the hon. Gentleman’s concerns. We are working closely with the Port Health Authority to make sure that everything that needs to be done can be done.
As I was saying, we exercise our plans regularly and work closely with stakeholders on their preparedness. The ongoing response to bluetongue and highly pathogenic avian influenza are cases in point. Officials from across the UK are working closely with sector representatives on the implementation of control measures.
Early identification was crucial in enabling a rapid response to the bluetongue outbreak. DEFRA provided free pre-movement testing to animal keepers in counties at the highest risk of incursion from infected biting midges originating from the continent. A restriction zone covering the counties affected by bluetongue has been established. That measure has been carefully considered to protect the free area from disease spread while allowing the free movement of animals in the zone, keeping business disruption to a minimum. On the question asked by the hon. Member for Epping Forest, permitted use of the BTV-3 vaccine is available, and I am told that just over 14,500 animals have been vaccinated so far.
To respond to my hon. Friend the Member for South Norfolk, I am aware of reports that some meat processors may have taken unfair advantage of the bluetongue outbreak to reduce prices. That is dreadful; I do not condone that behaviour at all, not least since bluetongue does not affect the meat. My understanding is that it is not a widespread issue, and that prices paid to farmers for beef and sheep continue to be stable and at five-year highs. That is a good example of why this Government consider fairness in the supply chain to be critical for farmers across all sectors. I also reassure hon. Members that the bluetongue virus is not a public health threat and does not affect people or food safety. While no sick animal should enter the food chain, meat and milk from infected animals is safe to eat and drink.
A number of hon. Members raised the issue of virus yellows. A lot of work is going on with British Sugar, particularly at the John Innes Centre, which is just outside Norwich; I understand that there is a project involving the biotech company Tropic. I have stood in fields and looked at sugar beet suffering to varying degrees from yellows. Our proposals on genetic engineering may provide a solution in future, but in the shorter term some new innovations are being looked at. Those should give us better ways of tackling this disease, which is serious, as my hon. Friend the Member for South Norfolk said—particularly for our region in the east of England.
On plant health in general, joint working with the horticultural sector takes place with the Royal Horticultural Society and the Horticultural Trades Association through the plant health accord, the tree health policy group and plant health advisory forum, and the Plant Health Alliance, which leads the plant healthy certification scheme.
As I have said, biosecurity has to be a shared endeavour. The Prime Minister and the President of the European Commission have agreed to strengthen the relationship between the European Union and the United Kingdom, and we are working with the European Union to identify areas where we can strengthen co-operation for mutual benefit. We have been clear that a veterinary and sanitary and phytosanitary agreement could boost trade and deliver significant benefits to the European Union and the United Kingdom, but delivering new agreements will take time. It is important that we get the right agreement, meet our international obligations, and protect the UK’s biosecurity and public health throughout the process.
Furthermore, maintaining our high standards requires constant investment. The hon. Member for Epping Forest made a powerful case about the Animal and Plant Health Agency at Weybridge. This Government are not in the business of making unfunded commitments, but we have announced £208 million for the next phase of the redevelopment of the Animal and Plant Health Agency’s Weybridge laboratory. I echo the powerful praise from my hon. Friend the Member for York Outer for Jenny Stewart and her staff—we should thank all those, right across the piece, who work on our behalf.
We believe that the £208 million investment will help to safeguard and enhance the UK’s capability to respond to the threat from animal and plant diseases, help to protect public health, and underpin the UK’s trade capability with animal export products, which are worth £16 billion per year to the UK economy. The APHA is also looking to grow its external income streams over the coming years to support the delivery of key services, recognising the efficiencies that we all need to deliver in these challenging times.
I have talked about bluetongue, so let me turn to the threat to our poultry sector.